TGFB1 and prostate carcinoma: Their findings revealed a positive correlation between AXL expression, TGF-β, and its receptor in disseminated prostate cancer cells, indicating a crucial crosstalk between TGF-β and the Gas6/Axl signaling pathways that regulate tumor dormancy.